Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drugs industry protecting ‘morally unacceptable’ patent system

17.07.2008
Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is “simply morally unacceptable”, a world-leading political philosopher will tell a major meeting of UK and European pharmacologists today (Thursday 17 July 2008).

Addressing an audience that will include senior figures from the pharmaceutical industry, Thomas Pogge, Professor of Philosophy and International Affairs at Yale University in the United States, will argue that international rules on intellectual property “violate the human rights of poor people by denying them access to vital medicines”.

He will go on to say that huge mortality and morbidity rates can be dramatically lowered by reforming the way the development of new medical treatments is funded.

In his AstraZeneca-sponsored lecture entitled, 'Advanced Medicines: Must We Exclude the Global Poor?', Pogge will propose an alternative licensing system called the Health Impact Fund (HIF) which he says is “required as an add-on to the existing system to render it human-rights compliant”.

The HIF would be a global agency, says Pogge, underwritten by governments. It would offer to reward the patentee of any new medicine, during its first decade or so, with annual payments proportional to this medicine’s demonstrated global health impact.

Registering a medicine with the Fund would be voluntary and require a concession affecting its price. Pogge says this would give innovators the opportunity to forgo “monopoly rents in favour of an alternative path that would provide ample rewards for the development of new high-impact medicines without excluding the poor from their use”.

Pogge will deliver his AstraZeneca-sponsored lecture on the final day of the Federation of European Pharmacological Societies (EPHAR) 2008 Congress, hosted by the British Pharmacological Society at The University of Manchester.

Speaking ahead of his lecture, Pogge said: “The main responsibility for change lies with politicians and citizens. But pharmaceutical companies are also citizens, and they play a significant role in the political process of most societies. They lobby a lot. And here I do see fault. They lobby for holding the line on a status quo that is simply morally unacceptable.

“They do this because they know the existing rules can have a profitable business model under them and are uncertain what alternative rules would be settled upon once the existing rules were found unacceptable.

“I want to change this conservative attitude. I want to give them an institutional reform that they can endorse and unite behind. I am convinced they would do better, on the whole, with the Health Impact Fund than without. I want to convince them of this. And I want to show them that, on balance, they have more to gain than to lose by supporting this reform.

“It will be harder and harder to hold the line on the existing system, and the HIF reform preserves pretty much everything they like about this system. In other words, they have both moral and strategic reasons to support the HIF.”

Pogge’s lecture is expected to provoke fierce debate at the conference, with many delegates holding alternative views.

Alex Waddington | alfa
Further information:
http://www.manchester.ac.uk

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Gran Chaco: Biodiversity at High Risk

17.01.2018 | Ecology, The Environment and Conservation

Only an atom thick: Physicists succeed in measuring mechanical properties of 2D monolayer materials

17.01.2018 | Physics and Astronomy

Fraunhofer HHI receives AIS Technology Innovation Award 2018 for 3D Human Body Reconstruction

17.01.2018 | Awards Funding

VideoLinks
B2B-VideoLinks
More VideoLinks >>>